Secondary cytoreduction for relapsed ovarian cancer - Authors' reply

Lancet Oncol. 2021 Jun;22(6):e233. doi: 10.1016/S1470-2045(21)00294-1.

¹ Ovarian Cancer Program, Department of Gynaecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
² Department of Gynaecologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China.
³ Department of Gynaecologic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
⁴ Ovarian Cancer Program, Department of Gynaecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: zang.rongyu@zs-hospital.sh.cn.

No abstract available

Publication types